Finance

Lists
ARX:NYSE
Accelerant Holdings
$19.80
+0.25%
(+0.050) 1D
Oct 9, 4:00:03 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ARX...
Open
$19.75
High
$19.80
Low
$19.74
Mkt. cap
4.30B
Avg. vol.
1.85M
Volume
0.00
52-wk high
$19.90
52-wk low
$9.18
EPS
-$6.65
Shares outstanding
118.55M
No. of employees
862
Open
$19.75
High
$19.80
Low
$19.74
Mkt. cap
4.30B
Avg. vol.
1.85M
Volume
0.00
52-wk high
$19.90
52-wk low
$9.18
EPS
-$6.65
Shares outstanding
118.55M
No. of employees
862
News stories
From web sources and news partners
About Accelerant Holdings
CEO-
Employees862
Founded2018
Headquarters-
SectorInsurance
Websiteaccelerant.ai
Analyst ratings
Based on 5 analysts giving stock ratings to ARX in the past 3 months
Hold
Buy
0
Hold
4
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for ARX in the last 3 months.
Highest
Current $19.80
$20.25 (+2.27%)
Average
$20.25 (+2.27%)
Lowest
$20.25 (+2.27%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andrew Kligerman
TD Cowen
Hold
Downgraded
$20.25
+2.3%
09/30/2026
Gregory Peters
Raymond James
Sell
Downgraded
-
-
09/23/2026
Unknown Analyst
TD Cowen
Buy
Maintained
$30.00
+51.5%
08/20/2026
Paul Newsome
Piper Sandler
Hold
Downgraded
$20.25
+2.3%
08/13/2026
Rowland Mayor
RBC Capital
Hold
Downgraded
$20.25
+2.3%
08/14/2026
Adam Klauber
William Blair
Hold
Downgraded
-
-
08/15/2026
Bob Huang
Morgan Stanley
Hold
Maintained
$14.00
-29.3%
07/06/2026
Randy Ollenberger
BMO Capital
Buy
Maintained
$17.00
-14.1%
06/16/2026
Elyse Greenspan
Wells Fargo
Buy
Reiterated
$17.00
-14.1%
05/18/2026
Robert Cox CFA
Goldman Sachs
Buy
Reiterated
$23.00
+16.2%
05/14/2026
Matthew Carletti
Citizens JMP
Buy
Maintained
$17.00
-14.1%
04/13/2026
Michael Zaremski
BMO Capital
Buy
Reiterated
$16.50
-16.7%
03/23/2026
Last report
Aug 13, 2026
Fiscal period
Q2 2026
$0.32 / $0.16
+96.32%beat
Revenue / Est. (USD)
323.70M / 285.62M
+13.33%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
217.80M
270.30M
261.10M
323.70M
Cost of goods sold
73.60M
78.90M
115.40M
106.50M
Cost of revenue
73.60M
78.90M
115.40M
106.50M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
115.80M
120.20M
123.80M
129.50M
Operating expense
144.00M
170.40M
151.50M
166.70M
Total operating expenses
217.60M
249.30M
266.90M
273.20M
Operating income
200.00K
21.00M
-5.80M
50.50M
Other non operating income
-
-
-
-
EBT including unusual items
-1.43B
-2.20M
2.00M
87.40M
EBT excluding unusual items
-1.37B
34.50M
1.90M
61.40M
Income tax expense
9.50M
-3.10M
6.10M
7.40M
Effective tax rate
-0.67%
140.91%
305.00%
8.47%
Other operating expenses
18.20M
41.90M
17.70M
26.80M
Net income
-1.44B
-600.00K
-5.20M
78.70M
Net profit margin
-661.02%
-0.22%
-1.99%
24.31%
Earnings per share
0.39
0.23
0.17
0.32
Interest and investment income
10.10M
18.80M
12.10M
7.20M
Interest expense
-1.38B
-
-2.50M
-2.40M
Net interest expenses
-1.37B
18.80M
9.60M
4.80M
Depreciation and amortization charges
10.00M
8.30M
10.00M
10.40M
EBITDA
10.20M
29.30M
4.20M
60.90M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps